It is of note, however, that the in vivo xenograft experiment was carried out with a colorectal cancer line, HT-29, that is wild-type for KRAS and NRAS, but harbors the activating V600E mutation in the BRAF gene. This evidence concerns the gene NRAS and colorectal cancer.